Edgewise Therapeutics

Edgewise Therapeutics

Biotechnology, 1715 38th St, Boulder, Colorado, 80301, United States, 51-200 Employees

edgewisetx.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 72********

Who is EDGEWISE THERAPEUTICS

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.

Read More

map
  • 1715 38th St, Boulder, Colorado, 80301, United States Headquarters: 1715 38th St, Boulder, Colorado, 80301, United States
  • 2017 Date Founded: 2017
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from EDGEWISE THERAPEUTICS

Edgewise Therapeutics Org Chart and Mapping

Employees

Maureen Franco

VP Corporate Communications

Badreddin Edris

Co-Founder & Board Member

Amanda Pustelnikas

Senior Clinical Research Associate

Ying Qian

Research Investigator

Charlotte Heyman

Director of Regulatory Affairs

Sara Cantrell

Senior Research Associate

Ericka Benson

Vice President Program Management

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Edgewise Therapeutics

Answer: Edgewise Therapeutics's headquarters are located at 1715 38th St, Boulder, Colorado, 80301, United States

Answer: Edgewise Therapeutics's phone number is 72********

Answer: Edgewise Therapeutics's official website is https://edgewisetx.com

Answer: Edgewise Therapeutics's revenue is $25 Million to $50 Million

Answer: Edgewise Therapeutics's SIC: 2834

Answer: Edgewise Therapeutics has 51-200 employees

Answer: Edgewise Therapeutics is in Biotechnology

Answer: Edgewise Therapeutics contact info: Phone number: 72******** Website: https://edgewisetx.com

Answer: Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access